Translational Development Acquisition (TDAC) Change in Accured Expenses (2024 - 2026)
Translational Development Acquisition's (TDAC) quarterly Change in Accured Expenses came in at -$12988.0 in Q1 2026, down 114.09% YoY from $92174.0 in Q1 2025, and down 48.06% on a QoQ basis from -$8772.0 in Q4 2025.
Translational Development Acquisition (TDAC) Change in Accured Expenses (2024 - 2026) Analysis & Trends
Translational Development Acquisition (TDAC) has 3 years of Change in Accured Expenses data on file, last reported at -$12988.0 in Q1 2026.
- Quarterly Change in Accured Expenses fell 114.09% year-over-year to -$12988.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$76154.0 (changed N/A YoY) and the FY2025 annual result came in at $29008.0, up 106.45% from the prior year.
- Change in Accured Expenses fell to -$12988.0 in Q1 2026, from -$8772.0 in the prior quarter.
- In the past five years, Change in Accured Expenses ranged from a high of $92174.0 in Q1 2025 to a low of -$469542.0 in Q4 2024.
- A 3-year average of -$61817.4 and a median of -$8772.0 in 2025 frame the typical range for Change in Accured Expenses.
- Annual changes were most pronounced in 2025 — Change in Accured Expenses jumped 98.13% — and 2026, when it sank 114.09%.
- Tracing TDAC's Change in Accured Expenses over 3 years: stood at -$469542.0 in 2024, then jumped by 98.13% to -$8772.0 in 2025, then tumbled by 48.06% to -$12988.0 in 2026.
- The last three Change in Accured Expenses figures came in at -$12988.0 (Q1 2026), -$8772.0 (Q4 2025), and $8163.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Accured Expenses (Qtr) |
|---|---|---|---|---|---|
| 1 | Oxley Bridge Acquisition | 585.76 Mn | 585.76 Mn | - | 1,000.00 |
| 2 | Launch Two Acquisition | 557.86 Mn | 557.86 Mn | - | 125,234.00 |
| 3 | Drugs Made In America Acquisition | 507.00 Mn | 507.00 Mn | - | - |
| 4 | Cantor Equity Partners IV | 468.00 Mn | 468.00 Mn | - | - |
| 5 | GP-Act III Acquisition | 401.06 Mn | 401.06 Mn | - | - |
| 6 | Aldel Financial | 397.49 Mn | 397.49 Mn | - | - |
| 7 | Republic Digital Acquisition | 389.25 Mn | 388.51 Mn | - | 153.00 |
| 8 | Gores Holdings X | 385.06 Mn | 384.87 Mn | - | - |
| 9 | Agriculture & Natural Solutions Acquisition | 377.29 Mn | 377.04 Mn | - | - |
| 10 | Translational Development Acquisition | 182.66 Mn | 182.57 Mn | - | 260,465.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -12,988.00 |
| Mar 31, 2026 | -12,988.00 |
| Dec 31, 2025 | -8,772.00 |
| Dec 31, 2025 | -8,772.00 |
| Sep 30, 2025 | 8,163.00 |
| Sep 30, 2025 | 8,163.00 |
| Jun 30, 2025 | -62,557.00 |
| Jun 30, 2025 | -62,557.00 |
| Mar 31, 2025 | 92,174.00 |
| Mar 31, 2025 | 92,174.00 |
| Dec 31, 2024 | -469,542.00 |
| Dec 31, 2024 | -469,542.00 |
| Sep 30, 2024 | 20,800.00 |
| Sep 30, 2024 | 20,800.00 |